Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 77 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Nuvectis Pharma, Inc. | 3,675,924 | reported | 06 Jan 2026 | tx 80+1,110,465 |
| KERYX BIOPHARMACEUTICALS INC | 777,209 | reported | 06 Apr 2015 | tx 65+2,833,228−1,109,998 |
| Beyond Air, Inc. | 40,000 | reported | 22 Nov 2024 | tx 53+434,976−500,320 |
| XTL BIOPHARMACEUTICALS LTD | 20,101 | reported | 21 Aug 2007 | tx 2+16,879 |
| STEMLINE THERAPEUTICS INC | 0 | reported | 10 Jun 2020 | tx 18+185,579−158,259 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 06 Jan 2026 | GRANT_AWARD | Nuvectis Pharma, Inc. | 150,000 | 0.00 USD | |
| 05 Nov 2025 | PURCHASE | Nuvectis Pharma, Inc. | 5,000 | 5.72 USD | |
| 02 Jan 2025 | GRANT_AWARD | Nuvectis Pharma, Inc. | 250,000 | 0.00 USD | |
| 24 Dec 2024 | PURCHASE | Nuvectis Pharma, Inc. | 4,500 | 4.65 USD | |
| 22 Nov 2024 | OTHER | Beyond Air, Inc. | 45,000 | — | deriv |
| 22 Nov 2024 | GRANT_AWARD | Beyond Air, Inc. | 45,000 | — | deriv |
| 22 Nov 2024 | OTHER | Beyond Air, Inc. | 40,000 | — | deriv |
| 22 Nov 2024 | GRANT_AWARD | Beyond Air, Inc. | 40,000 | — | deriv |
| 22 Nov 2024 | OTHER | Beyond Air, Inc. | 30,000 | — | deriv |
| 22 Nov 2024 | GRANT_AWARD | Beyond Air, Inc. | 24,000 | — | deriv |
| 22 Nov 2024 | OTHER | Beyond Air, Inc. | 25,000 | — | deriv |
| 22 Nov 2024 | GRANT_AWARD | Beyond Air, Inc. | 25,000 | — | deriv |
| 22 Nov 2024 | OTHER | Beyond Air, Inc. | 25,000 | — | deriv |
| 22 Nov 2024 | GRANT_AWARD | Beyond Air, Inc. | 25,000 | — | deriv |
| 22 Nov 2024 | OTHER | Beyond Air, Inc. | 24,000 | — | deriv |
| 22 Nov 2024 | GRANT_AWARD | Beyond Air, Inc. | 30,000 | — | deriv |
| 15 Nov 2024 | PURCHASE | Nuvectis Pharma, Inc. | 20,000 | 4.92 USD | |
| 14 May 2024 | PURCHASE | Nuvectis Pharma, Inc. | 1,940 | 6.74 USD | |
| 10 May 2024 | PURCHASE | Nuvectis Pharma, Inc. | 2,000 | 6.40 USD | |
| 20 Mar 2024 | GRANT_AWARD | Beyond Air, Inc. | 45,000 | 0.00 USD | deriv |
| 18 Mar 2024 | PURCHASE | Nuvectis Pharma, Inc. | 5,000 | 10.29 USD | |
| 10 Oct 2023 | PURCHASE | Nuvectis Pharma, Inc. | 640 | 11.08 USD | |
| 09 Oct 2023 | PURCHASE | Nuvectis Pharma, Inc. | 830 | 11.19 USD | |
| 06 Oct 2023 | PURCHASE | Nuvectis Pharma, Inc. | 250 | 11.27 USD | |
| 05 Oct 2023 | PURCHASE | Nuvectis Pharma, Inc. | 1,400 | 11.09 USD |
4 purchases reported after at least 12 months of silence — most recent on 04 Feb 2022.